Sunday, June 4, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense Headlines – April 2, 2012

by Global Biodefense Staff
April 2, 2012
Influenza News

See what we’re reading this week at Global Biodefense on topics like H5N1 Surveillance, DHS Funding for Biosurveillance, Synthetic Biology Fears, and E. coli Vaccines.

Does Foodborne Illness Trigger Lifeling Health Problems? (Wired)

H5N1 surveillance: Shift expertise to where it matters (Nature)

FDA seeks to stop CA fish producer, cites botulism risk (Food Safety News)

Antiviral drugs could blast the common cold—Should we use them? (Wired)

Studies confirm H1N1 vaccine-narcolepsy link in Finnish kids (CIDRAP)

Fear and loathing in synthetic biology reminiscent of other biotechnologies (GenEng News)

Public health: More than half of all cancers preventable (HSNW)

Related Posts

Biodefense Headlines – 25 April 2023
News Scan

Biodefense Headlines – 25 April 2023

April 25, 2023
Biodefense Headlines – 9 April 2023
News Scan

Biodefense Headlines – 9 April 2023

April 9, 2023
News Scan

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023
News Scan

Biodefense Headlines – 12 March 2023

March 12, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC